Environmental lead exposure and the kidney

References

• Putnam R. D. Review of toxicology of inorganic lead. Am. Ind. Assoc. J. 1986; 47: 700–703
   PubMed Web of Science ®Google Scholar
• Ritz E., De Broe M., Stoeppler M., Van De Vyver F. L., Koster J., D'Hase P. C., Wedeen R. P. Does lead contribute to deterioration of renal function in patients with renal disease?. Nephrology, Dialysis, Transplantation 1986; 1: 206
   PubMedGoogle Scholar
• Daelemans R., Eestermans G., D'Haese P. F., Van de Vyver L., Zachee P., Lins R. L., Verpooten G. A., Wedeen R. P., De Broe M. E., Stuivenberg A. Z. EDTA lead-mobilization and bone lead concentration in occult lead intoxication. Kidney Int. 1985; 30: 632–633
   Web of Science ®Google Scholar
• Hong C. D., Heneuson I. B., Lerner S., Hammond P. B., Pesce A. J., Pollok V. E. Occupational exposure to lead: effects on renal function. Kidney Int. 1980; 18: 489–496
   PubMed Web of Science ®Google Scholar
• Ibels L. S., Pollock C. A. Lead Intoxication. Med. Toxicol. 1986; 1: 387–410
   PubMedGoogle Scholar
• Malcolm D. The effects of lead on the kidney. Trans. Soc. Occup. Med. 1970; 20: 50–53
   PubMedGoogle Scholar
• Nriagu J. O. Saturnine gout among Roman Aristocracts. New Engl. J. Med. 1983; 308: 660–661
   PubMed Web of Science ®Google Scholar
• Lanceraux E. Nephrite et arthrite saturnines: coincidence de ces affections: parallele avec la nephrite et l'arthrite gouteusses. Arch, de Generales Medicines 1881; 6: 641–647
   Google Scholar
• Ollivier A. De albuminurie saturnine. Arch. Gen. De Med. Paris 1863; 2: 530–532
   Google Scholar
• Oliver T. Lead Poisoning. H. K. Lewis, London 1914
   Google Scholar
• Osler W. The Principles and Practice of Medicine. Appleton, London 1906; 695
   Google Scholar
• Smith S. A. Some Aspects of lead absorption. Med. J. Aust. 1925; 11: 391–392
   Google Scholar
• Cooper W. C., Gaffey W. R. Mortality of lead workers. J. Occup. Med. 1975; 17: 100–113
   PubMedGoogle Scholar
• Wedeen R. P. Poison in the Pot. Southern Illinois Press, Carbondale 1984
   Google Scholar
• Lane R. Mortality of battery pasters and lead workers. Br. J. Ind. Med. 1949; 6: 125–132
   PubMedGoogle Scholar
• Inglis J. A., Henderson D. A., Emmerson B. T. The pathology and pathogenesis of chronic lead nephropathy occurring in Queensland. J. Pathol 1978; 142: 65–73
   Google Scholar
• Murray R. E. Plumbism and chronic nephritis in young people in Queensland. Dept. of Health Service Publication, Commonwealth of Australia. 1939
   Google Scholar
• Gibson J. L. Australian Medical Gazette 1904; 23: 149–153
   Google Scholar
• Nye L. J. J. An investigation of the extraordinary incidence of chronic nephritis in young people in Queensland. Med. J. Aust. 1929; 2: 145–158
   Google Scholar
• Henderson D. A. Chronic nephritis in Queensland. Aust. Ann. Med. 1955; 4: 163–177
   PubMedGoogle Scholar
• Henderson D. A., Inglis J. A. The lead content of bone in chronic Bright's disease. Aust. Ann. Med. 1957; 6: 145–155
   PubMedGoogle Scholar
• Bennett W. Lead Nephropathy. Kidney Int. 1985; 28: 212–220
   PubMed Web of Science ®Google Scholar
• Pejic S. The nature of the primary renal lesion produced by lead. Ann. Intern. Med. 1928; 1: 577–604
   Google Scholar
• Tange J. D., Hayward N. J., Bremner D. A. Renal lesions in experimental plumbism and their clinical implications. Aust. Ann. Med. 1965; 14: 49–52
   PubMedGoogle Scholar
• Aviv A., Bernstein J., Goldsmith D. I., Spitzer A. Lead intoxication during development: its late effects on kidney function and blood pressure. Kidney Int. 1980; 17: 430–437
   PubMed Web of Science ®Google Scholar
• Goyer R. A., May P., Cates M. M., Krigman M. R. Lead and protein content of isolated intranuclear inclusion bodies from kidneys of lead-poisoned rats. Lab. Invest. 1970b; 22: 245–50
   PubMed Web of Science ®Google Scholar
• O'Flaherty Adams W.D., Hammond P. B., Taylor E. Resistance of the rat to development of lead-induced renal functional deficits. J. Toxicol. Environ. Health. 1986; 18: 61–75
   PubMed Web of Science ®Google Scholar
• Chang L. W., Wade P. R., Lee G. W. An ultrastructural reevaluation of lead-induced pathology in the kidney. Environ. Res. 1981; 26: 136–151
   PubMed Web of Science ®Google Scholar
• Fairhall L. T., Miller J. W. A study of the relative toxicity of the molecular compounds of lead arsenate. Public Health Report (Washington) 1941; 56: 1610–1625
   Google Scholar
• Shakerin, Paloucek. Intranuclear inclusions and renal tumors in rats fed lead subacetate. Lab. Invest. 1965; 14: 592–601
   Web of Science ®Google Scholar
• Blackman S. S. Intranuclear inclusion bodies in the kidney and liver caused by lead poisoning. Bulletin of the Johns Hopkins Hospital 1936; 58: 384–403
   Google Scholar
• Stiller D., Friedrich H. J. Ultrastructural and ultrahistochemical investigations of lead-induced intranuclear inclusion bodies in rat kidney. Exp. Pathol. 1983; 24: 133–139
   PubMedGoogle Scholar
• Van Esch G. J., Kroes R. The induction of renal tumours by feeding basic lead acetate to mice and hamsters. Br. J. Cancer 1969; 23: 765–771
   PubMed Web of Science ®Google Scholar
• Stowe H. D., Goyer R. A., Krigman M. N., Wilson M., Cates M. Experimental oral lead toxicity in young dogs: Clinical and morphologic effects. Arch. Pathol. 1973; 95: 106–116
   PubMedGoogle Scholar
• Hass G. M., Brown D. V., Eisenstein R., Hemmens A. Relations between lead poisoning in rabbit and man. Am. J. Pathol. 1964; 5: 692–715
   Google Scholar
• Choie D. D., Ritcher G. W., Young L. B. Biogenesis of intranuclear lead-protein inclusions in mouse kidney. Beitr. Pathol. 1975; 155: 197–201
   PubMedGoogle Scholar
• Fowler B. A., Kimmel C. A., Woods J. S., McConnell E. E., Grant L. D. Chronic low level toxicity in the rat, III: An integrated toxicological assessment with special reference to the kidney. Toxicol. Appl. Pharmacol. 1980; 56: 59–77
   PubMed Web of Science ®Google Scholar
• Goyer R. A. Lead and the kidney. Curr. Top. Pathol. 1971; 55: 147–76
   PubMedGoogle Scholar
• Allen J. R., McWay P. J., Suomi S. J. Pathobiological and behavioral effects of intoxication in the infant rhesus monkey. Environ. Health Perspect. 1984; 7: 239–246
   Google Scholar
• Murakami M., Kawamura R., Nishii S., Katsunuma H. Early appearance and localization of intranuclear inclusions in the segments of renal proximal tubules of rats following ingestion of lead. Br. J. Exp. Pathol. 1983; 64: 144–154
   PubMed Web of Science ®Google Scholar
• Oskarsson A., Fowler B. A. Effects of lead inclusion bodies on subcellular distribution of lead in rat kidney: the relationship to mitochondrial function. Exp. Mol. Pathol. 1985; 43: 397–403
   PubMed Web of Science ®Google Scholar
• Choie D. D., Richter G. W. Cell proliferation in mouse kidney induced by lead: I. Synthesis of DNA. Lab. Invest. 1974; 30: 647–653
   PubMed Web of Science ®Google Scholar
• Griffeth J. Q., Lindauer M. A. The effect of chronic lead poisoning on arterial blood pressure in rats. Am. Heart J. 1944; 28: 295–297
   Google Scholar
• Diaz-Rivera R. S., Horn R. C. Postmortem studies on hypertensive rats chronically intoxicated with lead acetate. Proc. Soc. Exp. Biol. Med. 1945; 59: 161–163
   Web of Science ®Google Scholar
• Sharp D. S., Becker B. E., Smith A. H. Chronic low-level lead exposure: its role in the pathogenesis of hypertension. Med. Toxicol. 1987; 2: 210–232
   PubMedGoogle Scholar
• Momcilovic B., Kostial K. Kinetics of lead retention and distribution in suckling and adult rats. Environ. Res. 1974; 8: 214–220
   PubMed Web of Science ®Google Scholar
• Brown D. R. Neonatal lead exposure in the rat. Toxicol. Appl. Pharmacol. 1975; 32: 628–633
   PubMed Web of Science ®Google Scholar
• Hirsch G. H. G. Effect of chronic lead treatment on renal function. Toxicol. Appl. Pharmacol. 1973; 25: 84–93
   PubMed Web of Science ®Google Scholar
• Cantarow A., Trumper C. Lead Poisoning. Williams & Wilkins Co., Baltimore, MD 1944; 72
   Google Scholar
• Port C. D., Baxter D. W. The mongolian Gerbil as a model for chronic lead toxicity. J. Comp. Pathol. 1975; 85: 119–131
   PubMed Web of Science ®Google Scholar
• Barry P. S. I. A comparison of concentration of lead in human tissues. Br. J. Ind. Med. 1975; 32: 119
   PubMedGoogle Scholar
• Delves H. T., Sherlock J. C., Quinn M. J. Temporal stability of blood lead concentrations in adults exposed only to environmental lead. Hum. Toxicol. 1984; 3: 279–288
   PubMedGoogle Scholar
• Choie D. D., Richter G. W. Effects of Lead on the Kidney. Lead Toxicity, R. L. Singal, J. A. Thomas. Urban & Schwarzenberg, Baltimore, Munich 1980; 187–204
   Google Scholar
• Drill S., Konz J., Mahar H., Morse M. The environmental lead problem: an assessment of lead in drinking water from a multi-media perspective, Office of Drinking Water, EPA 5570/9–79-003. EPA, Washington, D. C. 1979
   Google Scholar
• Annest J. L. Trends in the blood lead levels of the U. S. population: The second national health and nutrition examination survey (NHANES II) 1976–1980. Lead versus Health, M. Rutter, R. Jones, 1983; 33–58
   Google Scholar
• Sayre J. W., Charney E., Vostal J. House and hand dust as a potential source of childhood lead exposure. Am. J. Dis. Child. 1974; 127: 167–170
   PubMedGoogle Scholar
• Charney E., Sayre J., Coulter M. Increased lead absorption in inner city children: where does the lead come from?. Pediatrics 1980; 65: 226–231
   PubMed Web of Science ®Google Scholar
• Baker E. L., Folland D. S., Taylor T. A. Lead poisoning in children of lead workers: home contamination with industrial dust. N. Engl. J. Med. 1977; 296: 206–211
   PubMedGoogle Scholar
• Danilovic V. Chronic nephritis due to ingestion of lead contaminated flour. Br. Med. J. 1958; 1: 27–28
   PubMed Web of Science ®Google Scholar
• Jaworski J. F. The effects of lead in the Canadian environment. Associate Committee on Scientific Criteria for Environmental/Secretariat Publication Number NRC 16736, Ottawa 1979
   Google Scholar
• Rabinowitz M. B., Wetherhill G. W., Kopple J. D. Kinetic analysis of lead metabolism in healthy humans. J. Clin. Invest. 1976; 58: 260–270
   PubMed Web of Science ®Google Scholar
• Hryhorczuk D. O., Rabinowitz M. B., Hessl S. M., Hoffman D., Hogan M. M., Mallin K., Finch H., Orris P., Berman E. Elimination kinetics of blood lead in workers with chronic lead intoxication. Am. J. Ind. Med. 1985; 8: 33–42
   PubMed Web of Science ®Google Scholar
• Campbell B. C., Elliot H. L., Meredith P. A. Lead exposure and renal failure: does renal insufficiency influence lead kinetics?. Toxicol. Lett. 1981; 9: 121–124
   PubMed Web of Science ®Google Scholar
• Wedeen R. P., Maesaka J. K., Weimer B. Occupational lead nephropathy. Am. J. Med. 1975; 59: 630–641
   PubMed Web of Science ®Google Scholar
• Wedeen R. P., Batumen V. The safety of the EDTA mobilization test. Environ. Res. 1983; 30: 58–64
   PubMed Web of Science ®Google Scholar
• Araki S., Ushio K. Assessment of the body burden of chelatable lead: A model and its application to lead workers. Br. J. Ind. Med. 1982; 39(2)157–160
   PubMedGoogle Scholar
• Hammond P. B. The effects of chelating agents on the tissue distribution and excretion of lead. Toxicol. Appl. Pharmacol. 1971; 18: 296–310
   PubMed Web of Science ®Google Scholar
• Chisolm J. R., Baltrop D. Recognition and management of children with increased lead absorption. Arch. Dis. Child. 1979; 54: 249–254
   PubMed Web of Science ®Google Scholar
• Vitale L. F., Joselow M. M., Wedeen R. P., Pawlow M. Blood lead - An inadequate measure of occupational exposure. J. Occup. Med. 1975; 17: 155–156
   PubMedGoogle Scholar
• Wedeen R. P. The role of lead in renal failure. Clinical Experimental Dialysis Apheresis 1982; 6: 113–119
   PubMed Web of Science ®Google Scholar
• Aposhian H. V., Carter D. E., Hoover T. D., Hsu C., Maiorino R. M., Stine E. DMSA, DMPS, and DMPA - as arsenic antidotes. Fundam. Appl. Toxicol. 1984; 4: 558–564
   PubMedGoogle Scholar
• Aposhain H. V. DMSA and DMPS - Water soluble antidotes for heavy metal poisoning. Annu. Rev. Pharmacol. Toxicol. 1983; 23: 193
   PubMed Web of Science ®Google Scholar
• Lauwerys R. R., Bernard A. Early detection of the nephrotoxic effects of industrial chemicals: State of the art and future prospects. Am. J. Ind. Med. 1987; 11: 275–285
   PubMed Web of Science ®Google Scholar
• Lilis R., Fischbein A., Valciukas J., Blumberg W., Selikoff I. J. Renal function impairment in lead exposed workers: correlations with zinc protoporphyrin and blood lead levels. Mechanisms of Toxicity and Hazard Evaluation, B. Holmstedt, R. Lauwerys. Elsevier/North Biomedical Press. 1980; 363–371
   Google Scholar
• Meyer R. B., Fischbein A., Rosenman K., Lerman Y., Drayer D., Reidenberg M. Increased urinary enzyme excretion in workers exposed to nephrotoxic chemicals. Am. J. Med. 1984; 76: 989–998
   PubMed Web of Science ®Google Scholar
• Thun M. J., Clarkson T. W. Spectrum of tests available to evaluate occupationally induced renal disease. J. Occup. Med. 1986; 28: 1026–1033
   PubMedGoogle Scholar
• Sachs H., Moel D. Renal function 9–17 years after childhood lead poisoning. Kidney Int. 1985; 1: 152
   Google Scholar
• Goyer R. A., Leonard D. L., Moore J. F., Rhyne B., Krigman M. R. Lead dosage and the role of the intranuclear inclusion body. Arch. Environ. Health 1970; 20: 705–713
   PubMed Web of Science ®Google Scholar
• Cramer K., Goyer R. A., Jagenburg R., Wilson M. H. Renal ultrastructure, renal function, and parameter of lead toxicity in workers with different periods of lead exposure. Br. J. Ind. Med. 1974; 31: 113–127
   PubMedGoogle Scholar
• Landing B., Nakai H. Am. J. Clin. Pathol. 1959; 31: 499–511
   PubMed Web of Science ®Google Scholar
• Lilis R., Gavrilescu N., Nestorescu B., Dumitriu C., Roventa A. Nephropathy in chronic lead poisoning. Br. J. Ind. Med. 1968; 25: 168–173
   Google Scholar
• Henderson D. A. A follow-up of cases of plumbism in children. Austral. Ann. Med. 1954; 3: 219–224
   PubMedGoogle Scholar
• Tepper L. Renal function subsequent to childhood plumbism. Archives of Environment 1963; 7: 76–84
   PubMed Web of Science ®Google Scholar
• Craswell P. W., Lloyd H. M., Price J., Thomas B. J., Boyle P. D., Thomas B. W., Heazhood V. J., Williams G. M., Baddeley H. Chronic lead nephropathy in Queensland: alternative methods of diagnosis. Aust. N. Z. J. Med. 1986; 16: 11–19
   PubMedGoogle Scholar
• Campbell B. C., Beattie A. D., Moore M. R., Goldberg A., Reid A. G. Renal insufficiency associated with excessive lead exposure. Br. Med. J. 1977; 1: 482–485
   PubMed Web of Science ®Google Scholar
• Pocock S. J., Shaper A. G., Ashby D., Delves G., Whitehead T. P. Blood lead concentration, blood pressure and renal function. Br. Med. J. 1984; 2: 872–874
   Google Scholar
• Vaughan W. T. Lead poisoning from drinking “moonshine” whiskey. J. Am. Med. Assoc. 1922; 79: 966
   Google Scholar
• Morgan J. M., Hartley M. W., Miller R. E. Nephropathy in chronic lead poisoning. Arch. Intern. Med. 1966; 118: 17–29
   PubMed Web of Science ®Google Scholar
• Craswell P. W., Price J., Boyle P. D., Heazhood V. J., Williams G. M., Baddeley H., Lloyd H. M., Thomas B. J., Thomes B. W. Chronic renal failure with gout: a marker for chronic lead poisoning. Kidney Int. 1984; 26: 319–323
   PubMed Web of Science ®Google Scholar
• Ball G. V., Morgan J. M. Chronic lead ingestion and gout. South. Med. J. 1968; 61: 21
   Web of Science ®Google Scholar
• Campbell B. C., Moore M. R., Goldberg A., Hernandez L. A., Carson D. W. Subclinical lead exposure: a possible cause of gout. Br. Med. J. 1978; 2: 1403–1406
   PubMed Web of Science ®Google Scholar
• Garrod A. B. Second communication on the blood and effused fluids in gout, rheumatism and Bright's disease. Med. Chir. Trans. (London) 1854; 37: 49–53
   PubMedGoogle Scholar
• Lorimer G. Saturnine gout, and its distinguishing marks. Br. Med. J. 1886; 2: 163
   PubMedGoogle Scholar
• Emmerson B. T., Thiele B. R. Calcium versenate in the diagnosis of chronic lead nephropathy. Med. J. Aust. 1960; 1: 243–248
   Google Scholar
• Emmerson B. T. Chronic lead nephropathy: the diagnostic use of calcium-EDTA and the association with gout. Aust. Ann. Med. 1963; 12: 310–316
   PubMedGoogle Scholar
• Emmerson B. T. The clinical differentiation of lead gout from primary gout. Arthritis Rheum 1968; 11: 623–634
   PubMed Web of Science ®Google Scholar
• Emmerson B. T. Chronic lead nephropathy. Kidney Int. 1973; 4: 1–7
   PubMed Web of Science ®Google Scholar
• Emmerson B. T., Lecky D. S. The lead content of bone in subjects without recognized past lead exposure and in patients with renal disease. Aust. Ann. Med. 1963; 12: 139–142
   Google Scholar
• Emmerson B. T., Stride P. J., Williams G. The clinical differentiation of primary gout from primary renal disease in patients with both gout and renal diseases. J. Clin. Chem. Clin. Biochem. 1979; 17: 409–417
   Google Scholar
• Ball G. V., Sorensen L. B. Pathogenesis of hyperuricemia in saturnine gout. N. Engl. J. Med. 1969; 280: 1199–2003
   PubMed Web of Science ®Google Scholar
• Rapado A. Gout and saturnism. N. Engl. J. Med. 1969; 281: 851
   PubMed Web of Science ®Google Scholar
• Batuman V., Maesaka J. K., Haddad B., Tepper E., Landry E., Wedeen R. P. The role of lead in gout nephropathy. New Engl. J. Med. 1981; 304: 520–525
   PubMed Web of Science ®Google Scholar
• Craswell P., Boyle P., Low E., Behringer Ritz E., Stoeppler N. Patterns of lead excretion in patients with gout and chronic renal failure – a combined German and Australian study. Kidney Int. 1984; (A)26: 240
   Web of Science ®Google Scholar
• Wright L. F., Saylor R. P., Cecere F. A. Occult lead intoxication in patients with gout and kidney disease. J. Rheumatol. 1984; 11: 517–520
   PubMed Web of Science ®Google Scholar
• Reynolds P. P., Knapp M. J., Baraf H. S. B., Holmes E. W. Moonshine and lead. Arthritis Rheum. 1983; 26: 1057
   PubMed Web of Science ®Google Scholar
• Colleoni N., D'Amico G. Chronic lead accumulation as a possible cause of renal failure in patients with gout. Nephron 1986; 44: 32–35
   PubMed Web of Science ®Google Scholar
• Behringer D., Craswell P., Mohl C., Stoeppler M., Ritz E. Urinary lead excretion in uremic patients. Nephron 1986; 42: 323–329
   PubMed Web of Science ®Google Scholar
• Harlan W. R., Landis J. R., Schmouder R. L. Relationship of blood lead and blood pressure in the adolescent and adult U. S. population. J. Am. Med. Assoc. 1985; 253: 530–534
   PubMed Web of Science ®Google Scholar
• Pirkle J. L., Schwartz J., Landis J. R., Harlan W. R. The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol. 1985; 121: 246–258
   PubMed Web of Science ®Google Scholar
• Weiss S. T., Munoz A., Stein A., Sparrow D., Speizer F. E. The relationship of blood lead to blood pressure in a longitudinal study of working men. Am. J. Epidemiol. 1986; 123: 800–804
   PubMed Web of Science ®Google Scholar
• Belknap E. L. Clinical studies on lead absorption in the human. J. Ind. Hygiene and Toxicol. 1936; 18: 380–390
   Google Scholar
• Dressen W. C. Health of lead exposed storage battery workers. J. Ind. Hygiene and Toxicol. 1943; 2: 60–70
   Google Scholar
• Dingwall-Fordyce I., Lane R. E. A follow-up study of lead workers. Br. J. Ind. Med. 1963; 20: 313–315
   PubMedGoogle Scholar
• Cooper W. C., Wong O., Kheifets L. Mortality among employees of lead battery plants and lead-producing plants, 1947 – 1980. Scand. J. Work, Environ, and Health 1985; 11: 331–345
   PubMed Web of Science ®Google Scholar
• MacMichael A. J., Johnson H. M. Long-term mortality profile of heavily-exposed lead smelter workers. J. Occup. Med. 1982; 24: 375–378
   PubMedGoogle Scholar
• Batuman V., Landry E., Maesaka J. K., Wedeen R. P. Contribution of lead to hypertension with renal impairment. New Engl. J. Med. 1983; 309: 17–21
   PubMed Web of Science ®Google Scholar
• DeKort W. L. A. M., Verschoor M. A., Wibowo A. A. E., Van Hemmen J. J. Occupational exposure to lead and blood pressure: A study in 105 workers. Am. J. Ind. Med. 1987; 11: 145–156
   PubMed Web of Science ®Google Scholar
• March 31, 1982, NHANES II 1976–1980, Blood lead levels in the U. S. population, Morbidity and Mortality Weekly Report
   Google Scholar
• Lilis R., Fischbein A., Eisinger J., Blumberg W. E., Diammond S., Anderson H. A., Rom W., Rice C., Sarkozi L., Kon S., Selikoff I. J. Prevalence of lead disease answering secondary lead smelters and biological indicators of exposure. Environ. Res. 1977; 14: 255–285
   PubMed Web of Science ®Google Scholar